Diego A. Díaz García/X
Jun 13, 2025, 03:49
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events – mechanisms and therapeutic intervention
Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X:
“Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention. The gut microbiota plays a key role in irAE development, especially ICI-induced colitis. Microbial biomarkers and therapies like FMT offer new hope for managing irAEs.”
Title: Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention
Authors: Ya-Qi Gao, Yong-Jie Tan, Jing-Yuan Fang
Read the Full Article.
More posts featuring Diego A. Díaz García.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04
Jul 3, 2025, 09:50